Quiralam: A Selective Antimalarial Targeting DHODH

Quiralam is a novel antimalarial drug candidate designed to potently and selectively inhibit dihydroorotate dehydrogenase (DHODH), a key enzyme in pyrimidine synthesis. By blocking DHODH, Quiralam halts the replication of malaria parasites within red blood cells.

Trepanation - Related Articles